
Clinical trials are research studies that involve people. They answer questions of how a new medicine or treatment works in humans, and are the final step in a long process that often begins with laboratory research. Through clinical studies, doctors find new and better ways to prevent, detect, diagnose, control, and treat diseases such as cancer.
Clinical research is a key component of Dana-Farber/Harvard Cancer Center (DF/HCC). We offer more clinical trials than any other medical program in New England. Currently, more than 500 different trials are underway, addressing each of the different kinds of cancer. We see approximately 15,000 new cancer cases in our member institutions each year, with more than 2,500 patients enrolled in cancer center trials.
If you are considering participating in a clinical study, click here to view an award-winning video titled “Entering a Clinical Trial: Is It Right for You?” Or request a copy of the accompanying booklet or video (DVD or VHS).
Approximately 500 clinical trials for adults with cancer are currently underway at these DF/HCC hospitals: Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Beth Israel Deaconess Medical Center, and Massachusetts General Hospital. Individual trials may be open at all DF/HCC sites, but sometimes they are available at only a specific institution.
Clinical trials for children with cancer are conducted at two sites: Dana-Farber/Children’s Hospital Cancer Care and at Mass General Hospital for Children/Hematology and Oncology Center.